This evening we watched ShockWave Medical drop -8.2% to a price of $204.19 per share. The mid-cap Medical Instruments & Supplies company is now trading -28.33% below its average target price of $284.89. Analysts have set target prices ranging from $165.0 to $330.0 per share for ShockWave Medical, and have given the stock an average rating of buy.
The stock has an average amount of shares sold short at 2.3%, and a short ratio of 1.6. Since 1.18% of the company's shares are owned by insiders, we can infer that there is a degree of alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 93.3% of ShockWave Medical's shares being owned by this investor type.
Institutions Invested in ShockWave Medical
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2023-06-30 | Blackrock Inc. | 10% | 3,636,444 | $742,525,509 |
| 2023-06-30 | Vanguard Group Inc | 10% | 3,603,014 | $735,699,437 |
| 2023-06-30 | FMR, LLC | 7% | 2,434,974 | $497,197,347 |
| 2023-06-30 | Wellington Management Group, LLP | 4% | 1,352,723 | $276,212,512 |
| 2023-06-30 | Artisan Partners Limited Partnership | 3% | 1,147,784 | $234,366,017 |
| 2023-06-30 | Price (T.Rowe) Associates Inc | 3% | 1,091,050 | $222,781,502 |
| 2023-06-30 | State Street Corporation | 3% | 1,018,186 | $207,903,401 |
| 2023-06-30 | JP Morgan Chase & Company | 2% | 835,138 | $170,526,830 |
| 2023-06-30 | Invesco Ltd. | 2% | 773,776 | $157,997,323 |
| 2023-06-30 | Capital World Investors | 2% | 585,000 | $119,451,151 |
Besides an analyst consensus of strong upside potential, other market factors point to there being mixed market sentiment on ShockWave Medical.
